{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-12",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20221116",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 2",
          "submission_class_code_description": "Type 2 - New Active Ingredient",
          "application_docs": [
            {
              "id": "72622",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761215s000Orig2s000.lbl.pdf",
              "date": "20221116",
              "type": "Label"
            },
            {
              "id": "72635",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761215Orig2s000ltr.pdf",
              "date": "20221117",
              "type": "Letter"
            },
            {
              "id": "73009",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761215Orig2s000TOC.html",
              "date": "20221222",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20240809",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "79367",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761215s005lbl.pdf",
              "date": "20240812",
              "type": "Label"
            },
            {
              "id": "79376",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761215Orig1s005ltr.pdf",
              "date": "20240812",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20211217",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 2",
          "submission_class_code_description": "Type 2 - New Active Ingredient",
          "application_docs": [
            {
              "id": "69637",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761215s000lbl.pdf",
              "date": "20211219",
              "type": "Label"
            },
            {
              "id": "69724",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761215Orig1s000ltr.pdf",
              "date": "20211221",
              "type": "Letter"
            },
            {
              "id": "69987",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761215Orig1s000TOC.html",
              "date": "20220128",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA761215",
      "sponsor_name": "ELI LILLY CO",
      "openfda": {
        "application_number": [
          "BLA761215"
        ],
        "brand_name": [
          "REZVOGLAR KWIKPEN"
        ],
        "generic_name": [
          "INSULIN GLARGINE-AGLR"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-8980"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "INSULIN GLARGINE"
        ],
        "rxcui": [
          "2589008",
          "2589014"
        ],
        "spl_id": [
          "a9e95b4c-e280-4bef-a3dd-4907bfad6b4d"
        ],
        "spl_set_id": [
          "f6af8706-2058-4fe1-99c8-43684c20bfa2"
        ],
        "package_ndc": [
          "0002-8980-01",
          "0002-8980-05"
        ],
        "nui": [
          "M0011417",
          "N0000175453"
        ],
        "pharm_class_cs": [
          "Insulin [CS]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]"
        ],
        "unii": [
          "2ZM8CX04RZ"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "REZVOGLAR",
          "active_ingredients": [
            {
              "name": "INSULIN GLARGINE-AGLR",
              "strength": "3ML(100UNITS/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}